Acetylcholinesterase (AChE) inhibitors, both natural and synthetic, increase the cholinergic tone in the brain and are beneficial in Alzheimer's disease and cognitive enhancement. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.